Reports for GLICLAZIDE

Ingredient

GLICLAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-22 2018-06-12 36817
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-28 2021-02-16 127342
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
TARO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-12-03 2021-05-01 129474
MYLAN-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-10-29 2019-01-22 65715
MYLAN-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2021-01-20 2021-02-24 132033
TARO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-11 2019-04-15 75259
TARO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-02-24 2020-08-28 107082
TARO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2021-01-31 2021-05-01 132988

Showing 41 to 50 of 52

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
DIAMICRON 80MG TABLET Discontinued 2022-08-31 2022-10-03 168298
MYLAN-GLICLAZIDE 80MG TABLET Discontinued 2017-07-18 2017-12-02 16126
GLICLAZIDE-80 80MG TABLET Discontinued 2021-03-29 2021-03-30 136513

Showing 1 to 4 of 4